Why the study?
Does the s-EH inhibitor AR9276 reduce AAA formation and atherosclerosis in angiotensin II-infused apolipoprotein E-deficient mice?
Population
Six-month-old apolipoprotein E-deficient mice chronically infused with angiotensin II for 4 weeks to induce…
Comparison
s-EH inhibitor AR9276 for 4 weeks vs Vehicle for 4 weeks
Design
Preclinical
Follow-up
4 weeks
Authors
Loading...
Animal data on sEH inhibition in AAA warrant human trials; leaves open clinical relevance.
Does the s-EH inhibitor AR9276 reduce AAA formation and atherosclerosis in angiotensin II-infused apolipoprotein E-deficient mice?
Inhibition of soluble epoxide hydrolase with AR9276 attenuates AAA formation and atherosclerosis development in a mouse model, likely via lipid-lowering and anti-inflammatory effects.
Zhang et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: